ANEB

Anebulo Pharmaceuticals, Inc.

CIK 0001815974 · OTC

OTCHealth CarePharmaceutical Preparations

$0.34

↑ 0.00 (0.00%)

as of Jul 9, 2026

End-of-day close, not real-time intraday

Overall read: BearishOverall score · based on 3/4 lenses

FundamentalsOwnershipTechnicalsOptions

Risks: Fundamentals, Technicals; Excluded: Options (no data)

Key stats

Market Cap

$13.72M

P/E Ratio

-1.72

EPS

-0.25

Dividend Yield

Not covered

52W Position

10%

Beta

0.09

Valuation multiples

Fwd P/E

Not covered

PEG

Not covered

P/B

1.73

P/S

Not covered

EV/Revenue

Not covered

ROE

-100.5%

Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 10%

$0.01$3.42

Latest Financials

2025-06-30 FY

Revenue

–

Net Income

-$8.48M

Total Assets

$12.15M

Free Cash Flow

–

ANEB

Key stats

Valuation multiples

Price · 1Y

Latest Financials

Recent news

ANEB

Key stats

Valuation multiples

Price · 1Y

Latest Financials

Recent news